These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 26949121

  • 1. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 2. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F.
    Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [Abstract] [Full Text] [Related]

  • 4. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 5. Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Cho HJ, Koh KM, Kim HS, Lee TG, Kim CG, Kim JW.
    Am J Ophthalmol; 2013 Sep; 156(3):524-531.e1. PubMed ID: 23769197
    [Abstract] [Full Text] [Related]

  • 6. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 7. Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.
    de Silva SR, Bindra MS.
    Eye (Lond); 2016 Jul; 30(7):952-7. PubMed ID: 27080482
    [Abstract] [Full Text] [Related]

  • 8. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H, Bardak Y, Erçalık Y, Erdem B, Arslan G, Timlioglu S.
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
    Kim JH, Chang YS, Kim JW, Kim CG, Yoo SJ, Cho HJ.
    Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019
    [Abstract] [Full Text] [Related]

  • 10. Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor.
    Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ.
    Korean J Ophthalmol; 2015 Oct; 29(5):315-24. PubMed ID: 26457037
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
    Cho HJ, Koh KM, Kim JH, Kim HS, Han JI, Lew YJ, Lee TG, Kim JW.
    Retina; 2015 Feb; 35(2):205-12. PubMed ID: 25105310
    [Abstract] [Full Text] [Related]

  • 12. Anti-Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage.
    Shin JY, Choi HJ, Chung B, Choi M, Lee J, Byeon SH.
    Optom Vis Sci; 2016 Feb; 93(2):173-80. PubMed ID: 26704146
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH, Wu TT, Hong MC, Sheu SJ.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [Abstract] [Full Text] [Related]

  • 15. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Oct; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 16. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage.
    Shin JY, Lee JM, Byeon SH.
    Am J Ophthalmol; 2015 May; 159(5):904-14.e1. PubMed ID: 25637179
    [Abstract] [Full Text] [Related]

  • 17. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.
    González-López JJ, McGowan G, Chapman E, Yorston D.
    Eye (Lond); 2016 Jul; 30(7):929-35. PubMed ID: 27055681
    [Abstract] [Full Text] [Related]

  • 18. Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.
    Doi S, Kimura S, Morizane Y, Shiode Y, Hosokawa M, Hirano M, Hosogi M, Fujiwara A, Miyamoto K, Shiraga F.
    BMC Ophthalmol; 2015 Aug 07; 15():94. PubMed ID: 26250101
    [Abstract] [Full Text] [Related]

  • 19. Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Kim JH, Chang YS, Kim CG, Lee DW, Han JI.
    Graefes Arch Clin Exp Ophthalmol; 2018 Mar 07; 256(3):469-477. PubMed ID: 29302789
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Mar 07; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.